Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
Advertisement
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original contribution

Meticulous Control of Diabetes During Organogenesis Prevents Congenital Lumbosacral Defects in Rats

  1. Lester Baker,
  2. Joseph M Egler,
  3. Steven H Klein and
  4. Allen S Goldman
  1. Divisions of Endocrinology/Diabetes, Children's Hospital of Philadelphia Philadelphia
  2. Human Genetics/Teratology, Children's Hospital of Philadelphia Philadelphia
  3. Department of Pediatrics, University of Pennsylvania School of Medicine Philadelphia, Pennsylvania
  1. Address reprint requests to Lester Baker, M.D., Division of Endocrinology, Children's Hospital of Philadelphia, One Children's Center, 34th and Civic Center Blvd., Philadelphia, Pennsylvania, 19104.
Diabetes 1981 Nov; 30(11): 955-959. https://doi.org/10.2337/diab.30.11.955
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Lumbosacral defects occur in the offspring of the diabetic rat in a fashion analogous to those occurring in infants of diabetic human mothers. To test the hypothesis that control of diabetes during the critical period of organogenesis can affect the incidence of these defects, diabetes was produced by streptozotocin in pregnant rats on day 6 of gestation. One group of pregnant rats was treated with saline (group 2), while another (group 4) received insulin twice daily between days 6 and 13. The incidence of lumbosacral malformations in the fetuses was then compared between these groups, with a pregnant, nondiabetic control group (group 1), and with a group of rats in whom diabetes was produced by streptozotocin on day 12, after the critical period of fusion of the lumbosacral spine (group 3).

Two types of lumbar and/or sacral malformations were noted: a fusion defect and an ossification defect. In the nondiabetic animals (group 1), only 1 out of 59 fetuses had an abnormality. Diabetes produced after the period of fusion of the neural tube in the lumbosacral area (group 3) had no effect on the incidence of lumbosacral malformations (0 out of 54). Diabetes treated with saline during the period of organogenesis (group 2) was associated with lumbosacral malformations in 25 of 146 fetuses, which was significantly increased (P < 0.005) when compared with the nondiabetic pregnant animals. Insulin treatment during the period of organogenesis (group 4) significantly reduced (P < 0.005) the number of lumbosacral defects (5 of 106) from that observed in the diabetic animals treated with saline. When the results of the insulintreated diabetic group were further analyzed, the incidence of malformations (5 of 58) in the animals that exhibited intermediate hyperglycemia during the period of organ differentiation [two or more serum glucose values greater than 200 mg/dl, (group 4A)] was not significantly different from that observed in the saline-treated diabetic group (P > 0.1). This occurred despite a mean glucose concentration during the period of insulin treatment that was significantly lower than the saline-treated diabetic controls (180 ± 16 mg/dl vs. 348 ± 16, P < 0.001). In contrast, the incidence of lumbosacral malformations (0 of 48) observed in the fetuses of those diabetic animals in whom insulin therapy produced normal serum glucose concentrations (122 ± 9 mg/dl) during the period of organogenesis (group 4B) was sharply reduced from that seen in the fetuses taken from the saline-treated diabetic mothers who had not received insulin (P < 0.001).

These data are consistent with the thesis that (1) uncontrolled diabetes produces lumbosacral malformations only during the period of organ differentiation, (2) control of diabetes during the period of organ differentiation reduces the incidence of malformations, and (3) the “quality” of that control is quite important, because normal to near-normal serum glucose concentrations must be achieved in order to be effective.

  • Received November 24, 1980.
  • Revision received July 14, 1981.
  • Accepted July 14, 1981.
  • Copyright © 1981 by the American Diabetes Association

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
Advertisement

In this Issue

November 1981, 30(11)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Meticulous Control of Diabetes During Organogenesis Prevents Congenital Lumbosacral Defects in Rats
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
Citation Tools
Meticulous Control of Diabetes During Organogenesis Prevents Congenital Lumbosacral Defects in Rats
Lester Baker, Joseph M Egler, Steven H Klein, Allen S Goldman
Diabetes Nov 1981, 30 (11) 955-959; DOI: 10.2337/diab.30.11.955

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Meticulous Control of Diabetes During Organogenesis Prevents Congenital Lumbosacral Defects in Rats
Lester Baker, Joseph M Egler, Steven H Klein, Allen S Goldman
Diabetes Nov 1981, 30 (11) 955-959; DOI: 10.2337/diab.30.11.955
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Calculated Pattern of Intraportal Insulin Appearance Without Independent Assessment of C-Peptide Kinetics
  • Buffy Coat Transfusions in Early Type I Diabetes
  • Diminished Flare Response in Neuropathic Diabetic Patients: Comparison of Effects of Substance P, Histamine, and Capsaicin
Show more Original contribution

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • For Advertisers
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Scientific Sessions Abstracts
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org
Advertisement

© 2019 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.